STRATA Skin Sciences

STRATA Skin Sciences Targets Early CMS Reimbursement for Expanded XTRAC Laser Use, Cites New Vitiligo Study and Legal Victory

HORSHAM, PA — STRATA Skin Sciences, Inc. (NASDAQ: SSKN) announced it is collaborating with the Centers for Medicare & Medicaid Services (CMS) to expedite reimbursement access for its XTRAC® excimer laser …

STRATA Skin Sciences Targets Early CMS Reimbursement for Expanded XTRAC Laser Use, Cites New Vitiligo Study and Legal Victory Read More

Madrigal Pharmaceuticals

Madrigal Reports $212.8M in Q2 Rezdiffra Sales, Expands Global Pipeline and Secures $500M Financing

CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) reported strong second-quarter results, led by surging demand for Rezdiffraâ„¢, its recently launched treatment for metabolic dysfunction-associated steatohepatitis (MASH). The company also outlined …

Madrigal Reports $212.8M in Q2 Rezdiffra Sales, Expands Global Pipeline and Secures $500M Financing Read More